Omnipresent

Filter By Therapeutic Area

Reproductive Health

Allergy & Immunology

Gastroenterology

Interventional Cardiology

Microbiology & Infectious Diseases

Filter By Content Type

Overactive Bladder: Evaluation and Management

Overactive Bladder: Terminology, Controversies and Pathophysiology

Gene Signature Predicts Prostate Cancer Metastasis Risk

Smart Device Designed for Underactive Bladders

Q&A Webinar on the Management of Recurrent Cystitis

Higher Central Adiposity linked to Increased Risk of Prostate Cancer Death

Do COVID-19 Related Prostate Cancer Treatment Delays Impact Oncological Outcomes?

Master Class in Bladder Cancer: Practical Solutions to Common Scenarios in NMIBC

Liquid Biopsies of Over 1,000 Blood Samples from Men with Prostate Cancer Indicates Mens’ Response to Treatment

Could Sugars Provide Accurate Testing for Prostate Cancer Diagnosis?

Combined MRI Method as Superior Diagnostic Tool in Prostate Cancer

Large Trial Explores Antioxidant Treatment in Male Infertility

Prostate Cancer Risk Lowered by Active Lifestyle

Anthrax Combined with Growth Factor Kills Bladder Cancer Cells

Blood Test Could Replace Invasive Biopsies in Prostate Cancer Detection

Prostate Cancer Risk Linked to Increased Levels of Progenitor Cells

PD-1/PD-L1-Related Adverse Events Linked to Urothelial Carcinoma Outcomes

Combined Systematic and Targeted Biopsy Optimally Detects Prostate Cancer

EAU 2019 – Congress Highlights

EAU 2019 – Opening Ceremony

EAU 2019 – Interview – Prof Hendrik Van Poppel

New Insights into Prostate Cancer Treatment

A New Tool for Kidney Stone Prediction

Advancements and Trends in Urology

Pelvic Floor Exercises and Overactive Bladder

New Genes Linked to Prostate Cancer

Hyponatraemia Patients May Benefit from Treatment with Oral Urea

Hormone Therapy for Prostate Cancer May Increase the Risk of Liver Disease